Klivira
Request demo

Automating Fertility (REI) GLP-1 Prior Auth for Reproductive Health

For fertility (REI) clinics, managing the increasing volume of GLP-1 prior auth requests presents a unique challenge, often tied to complex patient profiles and specific treatment pathways.

Reproductive endocrinology and infertility (REI) practices frequently encounter patients for whom GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound are clinically indicated, either for type 2 diabetes management or weight loss. Navigating the diverse payer policies, step therapy requirements, and documentation nuances for these high-volume medications can significantly burden PA teams, diverting resources from core fertility care.

The Role of GLP-1s in Reproductive Health and Associated PA Burdens

Patients in fertility (REI) clinics often present with comorbidities such as PCOS, obesity, and insulin resistance, where GLP-1 receptor agonists like Ozempic, Mounjaro, Wegovy, and Zepbound may be prescribed. These prescriptions add to the already high prior authorization volume for fertility specialty drugs, IVF cycles, and fertility preservation procedures, creating significant administrative overhead for PA coordinators.

Navigating Complex GLP-1 PA Criteria for Fertility Patients

Prior authorization criteria for GLP-1s, including BMI thresholds, A1C levels, and step therapy requirements (e.g., metformin trials), become particularly intricate when applied to fertility patients. Payer coverage often varies significantly between type 2 diabetes and obesity indications, directly impacting access to medications crucial for managing conditions that affect reproductive health.

Klivira's Automated Workflow for Fertility (REI) GLP-1 Prior Auth

  • **Indication-Aware Routing:** Klivira's engine differentiates between type 2 diabetes and obesity indications from EMR diagnosis and clinical context, critical for varying payer policies relevant to fertility patients.
  • **Payer-Specific Obesity Coverage:** Our policy engine maintains per-payer obesity benefit status for anti-obesity medications, routing requests accordingly to optimize approval rates for fertility-related prescriptions.
  • **Automated Documentation:** Klivira pulls essential clinical data such as BMI, A1C, and metformin trial history directly from the EMR via FHIR, fulfilling step therapy requirements for GLP-1s like Wegovy and Zepbound.
  • **Brand-Specific Logic:** The platform applies unique PA criteria for different GLP-1 products (e.g., Ozempic, Mounjaro, Saxenda), ensuring accurate submission tailored to each drug's requirements.
  • **Specialty Pharmacy Coordination:** Post-approval, Klivira facilitates seamless routing to specialty pharmacies for many GLP-1 products, streamlining fulfillment for fertility patients.
  • **Patient Financial Guidance:** When obesity-related GLP-1s are denied, Klivira can surface manufacturer copay programs and alternative coverage paths, supporting patient access in challenging financial scenarios.

EMR Integration and Data Exchange for Seamless REI Workflows

Klivira integrates deeply with major EMR systems using SMART on FHIR, enabling automated extraction of patient demographics, diagnoses, lab results, and medication history for GLP-1 prior authorization forms. This robust data exchange, coupled with connectivity to payers via X12 278 transactions and ePA channels, is essential for high-volume fertility practices managing complex medication regimens.

Enhancing Efficiency and Patient Access in Fertility Care

Automating fertility (REI) GLP-1 prior auth reduces the significant administrative burden on staff, allowing PA coordinators to focus on more complex cases. This efficiency accelerates time-to-treatment for critical reproductive health interventions, minimizes denials that can delay or disrupt fertility journeys, and ultimately improves the patient experience by providing faster access to necessary medications.

Frequently asked questions

How does Klivira differentiate GLP-1 indications for fertility patients?

Klivira's policy engine identifies whether a GLP-1 is prescribed for type 2 diabetes or obesity based on EMR data. This distinction is crucial as payer coverage for these indications can vary significantly, directly impacting the prior authorization outcome for fertility patients.

What specific EMR data points does Klivira automate for GLP-1 PAs in an REI setting?

Klivira leverages SMART on FHIR to extract relevant clinical data, including BMI, A1C levels, diagnosis codes, and documentation of prior medication trials like metformin. This automation ensures that all necessary clinical evidence for GLP-1 prior authorizations is accurately submitted for fertility patients.

Can Klivira handle step therapy protocols for GLP-1s when prescribed for fertility-related conditions?

Yes, Klivira automates the documentation and submission of step therapy requirements. For GLP-1s, this often includes verifying trials of less expensive or first-line medications, such as metformin, which is particularly relevant for fertility patients with conditions like PCOS.

How does automating GLP-1 PAs benefit patient care in fertility clinics?

Automation significantly reduces administrative delays, leading to faster prior authorization approvals for GLP-1 medications. This rapid turnaround ensures fertility patients can access their prescribed treatments without unnecessary interruptions, supporting their overall reproductive health journey and improving patient satisfaction.

Does Klivira integrate with specialty pharmacies for GLP-1 medications common in fertility treatment?

Yes, Klivira's workflow includes post-approval routing to specialty pharmacies for many GLP-1 products. This integration streamlines the fulfillment process, ensuring that once authorized, these often high-cost and specialized medications are delivered efficiently to fertility patients.

Related coverage

Other fertility-reproductive prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo